Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Maria, Davydova"'
Autor:
Elena Bakhrushina, Liliya Buraya, Egor Moiseev, Marina Shumkova, Maria Davydova, Ivan Krasnyuk
Publikováno v:
Sciences of Pharmacy. 2:37-45
Abiraterone acetate is one of the effective therapies in castration-resistant prostate cancer. There is only one dosage form in the form of film-coated tablets. Abiraterone has proven effective but has disadvantages and contraindications that complic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::567ac8d0fc03bbd6ea266bdf9bbfe2ea
https://doi.org/10.58920/sciphar02020037
https://doi.org/10.58920/sciphar02020037
Autor:
Jason S. Lewis, Nagavarakishore Pillarsetty, Thomas R. Dilling, Maria Davydova, Ian L. Fox, Adam O. Michel, Mike Cornejo, Veronica L. Nagle, Kyeara N. Mack, Kelly E. Henry
Supplementary Materials and Methods. Supplementary Figure 1. Fibroblast isolation from orthotopic PDAC tumor microenvironment. Supplementary Figure 2. Controls for immunofluorescence experiments to confirm no cross-reactivity or non-specific binding,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a066b185f31d6aaf3af1dfcc88dc5d34
https://doi.org/10.1158/1535-7163.22520551.v1
https://doi.org/10.1158/1535-7163.22520551.v1
Autor:
Jason S. Lewis, Nagavarakishore Pillarsetty, Thomas R. Dilling, Maria Davydova, Ian L. Fox, Adam O. Michel, Mike Cornejo, Veronica L. Nagle, Kyeara N. Mack, Kelly E. Henry
Patients with pancreatic ductal adenocarcinoma (PDAC) do not benefit from immune checkpoint blockade (ICB) along the PD-1/PD-L1 axis. Variable PD-L1 expression in PDAC indicates a potential access issue of PD-L1–targeted therapy. To monitor target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8891e60b9376a9e53f82e6eda47b7a41
https://doi.org/10.1158/1535-7163.c.6542677.v1
https://doi.org/10.1158/1535-7163.c.6542677.v1
Autor:
Simon Puttick, Jeroen A.C.M. Goos, Maria Davydova, William S. Price, John F. Quinn, Thomas P. Davis, Abhishek Gupta, Mike Cornejo, Michael R. Whittaker, Jason S. Lewis, Thomas R. Dilling, Andrew Cho
Publikováno v:
Nucl Med Biol
INTRODUCTION: Pretargeting strategies that do not rely on the expression of molecular targets have expanded imaging and therapy options for cancer patients. Nanostars with designed multivalency and which highly accumulate in tumor tissue via the enha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a72d719eb175b5ee3230638a7bd09e74
https://doi.org/10.1016/j.nucmedbio.2020.02.012
https://doi.org/10.1016/j.nucmedbio.2020.02.012
Autor:
Jason S. Lewis, Michael R. Whittaker, Jeroen A.C.M. Goos, Thomas P. Davis, Abhishek Gupta, Simon Puttick, Maria Davydova, William S. Price, Thomas R. Dilling, John F. Quinn, Komal Mandleywala, Lukas M. Carter, Andrew Cho
Publikováno v:
Theranostics
Expression levels of biomarkers are generally unknown at initial diagnosis. The development of theranostic probes that do not rely on biomarker availability would expand therapy options for cancer patients, improve patient selection for nanomedicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f351d7b3313f4d7d0b72dee0e9809f36
https://doi.org/10.7150/thno.36777
https://doi.org/10.7150/thno.36777
Autor:
Maria Davydova
Сборник научных трудов отечественных и зарубежных ученых посвящен юбилею доктора филологических наук, профессора Г.Г. Молчановой. В нем
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42eec02166b8a244bbb9d8746edd15c9
https://doi.org/10.31453/kdu.ru.91304.0134
https://doi.org/10.31453/kdu.ru.91304.0134
Autor:
Mike Cornejo, Jason S. Lewis, Ian L. Fox, Thomas R. Dilling, Adam O. Michel, Kelly E. Henry, Nagavarakishore Pillarsetty, Maria Davydova, Veronica L. Nagle, Kyeara N. Mack
Publikováno v:
Mol Cancer Ther
Patients with pancreatic ductal adenocarcinoma (PDAC) do not benefit from immune checkpoint blockade (ICB) along the PD-1/PD-L1 axis. Variable PD-L1 expression in PDAC indicates a potential access issue of PD-L1–targeted therapy. To monitor target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f8765325d41917d3d55ab80fbebebd5
https://pubmed.ncbi.nlm.nih.gov/34349003
https://pubmed.ncbi.nlm.nih.gov/34349003
Autor:
Jeroen A C M, Goos, Maria, Davydova, Nigel, Lengkeek, Ivan, Greguric, Michael R, Whittaker, John F, Quinn, Jonathan B, Baell, Jason S, Lewis, Thomas P, Davis
Publikováno v:
Macromol Rapid Commun
To improve the signal-to-noise ratio of hypoxia positron emission tomography (PET) imaging, stimuli-responsive polymers are designed for the delivery of the hypoxia PET tracer fluorine-18 labeled fluoromisonidazole ([(18)F]FMISO). Linear poly(N-(2-(h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e088b34d2a5a115c787a5e2475d052a7
https://pubmed.ncbi.nlm.nih.gov/32250004
https://pubmed.ncbi.nlm.nih.gov/32250004
Publikováno v:
Bioconjugate Chemistry. 29:1364-1372
Maleimide-bearing bifunctional chelators have been used extensively for the site-selective bioconjugation and radiolabeling of peptides and proteins. However, bioconjugates obtained using these constructs inevitably suffer from limited stability in v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19a1065fb4f7ee1e9d9e99e3ccf83671
https://doi.org/10.1021/acs.bioconjchem.8b00081
https://doi.org/10.1021/acs.bioconjchem.8b00081
Publikováno v:
Journal of Visualized Experiments.
Maleimide-bearing bifunctional probes have been employed for decades for the site-selective modification of thiols in biomolecules, especially antibodies. Yet maleimide-based conjugates display limited stability in vivo because the succinimidyl thioe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b2742c2131892258489fb50fd37778
https://doi.org/10.3791/59063
https://doi.org/10.3791/59063